(Q42255181)

English

Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine

scientific article published on September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

8

object named as

Woo Joo Kim

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Joon Young Song

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hee Jin Cheong

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Ji Yun Noh

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yu Bin Seo

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Won Suk Choi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Geum Joo Cho

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Taik Gun Hwang

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1591-1597

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Influenza vaccine immunology

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Summer influenza outbreak in a home for the elderly: application of preventive measures

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Immunogenicity and protective efficacy of influenza vaccination

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Real-time monitoring of the influenza vaccine field effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23630

21 January 2018

Identifiers

10.1002/JMV.23630

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42255181&oldid=1940310967"